Conglomerate boosts China's push to revolutionise its health sector by buying US biotech pioneer Dendreon. It complements Sanpower's previous investment in more prosaic health assets.
Zhengzhou Coal Mining Machinery and Fosun Pharmaceutical — both already listed in Shanghai — seek to raise a combined $1 billion through their offerings.
Robust demand from high-quality institutions allows the majority owner to sell more shares than planned in Tempo Scan, an Indonesian pharmaceutical and consumer products company.
Regional finance director Henryady Sudjana explains why the pharmaceutical company Actavis is implementing a centralised regional treasury in Indonesia.